China Respiratory Care Device Market Size, Share, Trends and Forecasts 2031

Key Findings

• The China Respiratory Care Devices Market is experiencing strong growth due to the increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea.
• Rising pollution levels, tobacco consumption, and aging populations are major factors accelerating demand for respiratory care devices across China.
• Technological advancements in ventilators, nebulizers, and oxygen concentrators are improving patient outcomes and expanding home-care applications.
• The growing adoption of non-invasive ventilation (NIV) and portable respiratory devices is transforming long-term respiratory therapy management.
• Hospitals, clinics, and home healthcare providers in China are increasingly deploying advanced respiratory monitoring and treatment systems.
• Challenges such as high equipment costs, limited access in rural areas, and shortage of trained respiratory therapists hinder broader adoption.
• Strategic partnerships between healthcare institutions and medical device manufacturers are expanding the reach of affordable respiratory technologies across China.

China Respiratory Care Devices Market Size and Forecast

The China Respiratory Care Devices Market is projected to grow from USD 22.3 billion in 2025 to USD 39.5 billion by 2031, at a CAGR of 9.8% during the forecast period. This growth is fueled by the rising incidence of respiratory disorders and increasing awareness of early diagnosis and management. Respiratory care devices comprising therapeutic, diagnostic, and monitoring equipment play a crucial role in assisting patients with compromised breathing function. In China, growing healthcare investments and the shift toward home-based respiratory therapy are expanding the market scope. Government initiatives supporting chronic disease management, alongside the increasing number of ICU installations and ventilator capacity upgrades, are expected to further accelerate market expansion over the next decade.

Introduction

Respiratory care devices are medical systems designed to assist, monitor, and treat patients suffering from acute or chronic pulmonary conditions. These devices are essential in critical care settings, emergency rooms, and home healthcare environments. In China, the demand for respiratory care devices has surged due to the rising prevalence of chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and other respiratory disorders. The COVID-19 pandemic further highlighted the importance of robust respiratory infrastructure and accelerated innovation in mechanical ventilation and oxygen delivery systems. As healthcare systems in China evolve toward preventive and home-based care models, respiratory devices are playing a pivotal role in enhancing patient mobility, comfort, and long-term disease management.

Future Outlook

By 2031, the China Respiratory Care Devices Market will become highly technology-driven, integrating AI, IoT, and telemedicine for real-time patient monitoring and personalized therapy. Portable and wearable respiratory systems will become more prevalent, offering patients continuous care outside traditional clinical settings. Advancements in sensor technology and smart analytics will improve diagnostic precision and treatment optimization. The introduction of eco-friendly and low-noise ventilators will enhance patient comfort and sustainability. Furthermore, the healthcare industry in China will focus on developing local manufacturing capabilities to reduce import dependency and improve cost efficiency. As awareness of respiratory health continues to grow, respiratory care devices will remain at the forefront of chronic disease management and acute care delivery in China.

China Respiratory Care Devices Market Trends

• Increasing Demand for Home-Based Respiratory Therapy
  Home healthcare adoption is growing rapidly in China as patients seek cost-effective and convenient respiratory care solutions. Portable oxygen concentrators, nebulizers, and CPAP/BiPAP devices are becoming standard equipment for home treatment of COPD and sleep apnea. The availability of compact, battery-operated, and user-friendly devices allows patients to maintain independence while managing chronic conditions. Healthcare providers are promoting home-based therapy as a means to reduce hospital congestion and overall treatment costs. This trend is expected to continue as the population ages and healthcare systems prioritize decentralized care.

• Technological Advancements in Ventilation Systems
  The development of next-generation ventilators and non-invasive ventilation (NIV) systems is revolutionizing critical respiratory care in China. Modern ventilators now include adaptive pressure control, wireless monitoring, and AI-based parameter optimization. The shift from invasive to non-invasive ventilation techniques is improving patient comfort and reducing complications associated with intubation. Integration with cloud-based platforms enables remote monitoring and data analytics, empowering clinicians to make faster and more accurate decisions. Continuous innovations in ventilation technologies are driving market penetration in both hospital and home settings.

• Rising Prevalence of Chronic Respiratory Diseases (CRDs)
  The growing incidence of COPD, asthma, and pulmonary fibrosis is significantly driving the need for respiratory support equipment in China. Industrial emissions, vehicular pollution, and smoking habits are major contributors to the increasing burden of respiratory diseases. Healthcare systems are responding by expanding pulmonary rehabilitation programs and investing in diagnostic tools such as spirometers and capnography devices. Awareness campaigns and early screening initiatives are further enhancing the use of respiratory care products. The sustained rise in chronic respiratory disease prevalence is ensuring strong long-term demand for respiratory devices.

• Adoption of Digital and Connected Respiratory Devices
  The integration of digital connectivity and IoT technology in respiratory care equipment is transforming patient monitoring in China. Connected inhalers, smart CPAP devices, and app-based monitoring systems allow clinicians to track adherence and therapeutic efficacy in real time. Data-driven insights support personalized treatment adjustments and reduce readmission rates. The shift toward connected devices is also improving long-term disease management, particularly in sleep apnea and chronic pulmonary conditions. The growing acceptance of telehealth and remote respiratory monitoring is expected to significantly boost market adoption.

• Sustainability and Eco-Friendly Device Development
  Environmental sustainability is becoming a key focus area for respiratory device manufacturers in China. Companies are developing recyclable, energy-efficient, and low-emission devices that align with green healthcare initiatives. The use of biocompatible materials and noise reduction technology enhances patient comfort while minimizing environmental impact. Hospitals and clinics are increasingly preferring equipment with lower energy consumption and sustainable manufacturing processes. This trend reflects a broader shift toward eco-conscious healthcare delivery.

Market Growth Drivers

• Increasing Incidence of Respiratory Disorders and Aging Populations
  The rising prevalence of chronic respiratory conditions in China, fueled by aging demographics and lifestyle changes, is one of the major growth drivers. Older adults are more prone to respiratory complications due to weakened pulmonary function and comorbidities. As the elderly population continues to expand, demand for long-term oxygen therapy, non-invasive ventilation, and monitoring devices will increase substantially. Healthcare systems are prioritizing early diagnosis and management to improve patient survival and quality of life.

• Rapid Expansion of Healthcare Infrastructure and ICU Capacity
  Significant investments in hospital infrastructure, particularly in critical care units, are driving demand for respiratory care equipment. The COVID-19 pandemic underscored the importance of mechanical ventilation and oxygen supply systems, prompting healthcare institutions in China to strengthen respiratory preparedness. New ICU installations and upgrades to existing facilities are incorporating advanced ventilators and patient monitoring devices. This infrastructure expansion continues to propel market growth across both public and private healthcare sectors.

• Technological Advancements Enhancing Patient Safety and Comfort
  Modern respiratory devices in China are designed to provide superior patient comfort through intelligent control systems and ergonomic designs. Features such as automatic pressure adjustment, humidity control, and noise reduction enhance user experience. Moreover, integration with AI algorithms allows continuous optimization of ventilation parameters, minimizing manual intervention. These advancements are improving treatment outcomes, boosting patient compliance, and expanding device adoption across healthcare settings.

• Government Health Initiatives and Public Awareness Programs
  Governments in China are actively promoting respiratory health through national screening initiatives, tobacco control programs, and funding for pulmonary rehabilitation. Public health campaigns emphasizing early diagnosis and preventive care have improved awareness about respiratory diseases and treatment options. Favorable reimbursement policies for respiratory equipment, along with reduced import tariffs, are encouraging broader accessibility. The alignment of public health goals with technological innovation is reinforcing market expansion across China.

• Rising Adoption of Non-Invasive and Portable Respiratory Solutions
  Non-invasive respiratory devices such as CPAP, BiPAP, and nasal oxygen therapy systems are gaining popularity in China due to their ease of use and reduced risk of complications. Portable devices enable mobility and improve patient quality of life, especially for those requiring long-term oxygen therapy. The increasing preference for home-based and outpatient treatment models is further stimulating demand for compact and wearable respiratory systems. These solutions are transforming chronic disease management into a patient-centric, accessible, and cost-effective process.

Challenges in the Market

• High Cost of Equipment and Limited Reimbursement Coverage
  Advanced respiratory care devices such as ventilators and portable concentrators involve high initial investment and maintenance costs. In China, limited reimbursement coverage for home-based respiratory therapies restricts patient access. The financial burden on hospitals and patients, particularly in low-income regions, continues to slow adoption. Cost reduction through local manufacturing and government subsidies will be critical to overcoming this challenge.

• Shortage of Trained Respiratory Therapists and Technical Expertise
  The effective use of respiratory care equipment requires specialized training in device operation and patient management. In China, a shortage of skilled respiratory therapists and biomedical engineers limits the full utilization of advanced devices. This gap often results in improper equipment handling and inconsistent clinical outcomes. Investment in workforce training and certification programs is essential to ensure optimal usage and maintenance of respiratory devices.

• Regulatory and Import Dependency Constraints
  The reliance on imported respiratory devices exposes healthcare systems in China to supply chain disruptions and currency fluctuations. Inconsistent regulatory frameworks across regions can delay product approvals and market entry. The lack of harmonized certification standards further complicates compliance for international manufacturers. Streamlining regulatory pathways and promoting domestic production will help stabilize market growth and ensure consistent supply.

• Maintenance, Calibration, and Technical Downtime
  Respiratory devices require regular servicing and calibration to maintain accuracy and reliability. In China, inadequate technical support and maintenance infrastructure can lead to operational downtime and compromised patient care. Hospitals face challenges in accessing spare parts and qualified service providers, especially in rural regions. Building after-sales support networks and providing remote diagnostics can mitigate these operational risks.

• Patient Compliance and Device Management Issues
  For home-based therapies, patient adherence to respiratory devices such as CPAP and oxygen concentrators remains inconsistent due to discomfort or noise. Lack of user education and poor device management often lead to suboptimal outcomes. Manufacturers are addressing this by developing quieter, lightweight, and easy-to-use models with integrated usage feedback systems. Enhancing patient training and follow-up care will be crucial for improving therapy compliance rates.

China Respiratory Care Devices Market Segmentation

By Product Type

• Therapeutic Devices (Ventilators, CPAP/BiPAP Devices, Oxygen Concentrators, Nebulizers, Humidifiers)

• Monitoring Devices (Capnography, Pulse Oximeters, Spirometers)

• Diagnostic Devices (Peak Flow Meters, Gas Analyzers, Sleep Testing Devices)

• Consumables and Accessories (Masks, Tubes, Filters, Valves)

By End-User

• Hospitals and Clinics

• Home Healthcare Settings

• Ambulatory Surgical Centers

• Specialty Pulmonary Centers

By Disease Indication

• Chronic Obstructive Pulmonary Disease (COPD)

• Asthma

• Sleep Apnea

• Acute Respiratory Distress Syndrome (ARDS)

• Cystic Fibrosis

• Others

Leading Key Players

• Philips Healthcare

• ResMed Inc.

• Medtronic plc

• GE HealthCare Technologies, Inc.

• Drägerwerk AG & Co. KGaA

• Fisher & Paykel Healthcare Corporation Limited

• Nihon Kohden Corporation

• Vyaire Medical, Inc.

• Mindray Medical International Limited

• Invacare Corporation

Recent Developments

• Philips Healthcare launched a next-generation portable ventilator with integrated AI-driven pressure optimization for home and hospital use in China.

• ResMed Inc. expanded its digital sleep apnea solutions by introducing smart CPAP devices with remote compliance tracking in China.

• Drägerwerk AG & Co. KGaA introduced a new line of critical care ventilators designed for low-flow oxygen environments in rural hospitals across China.

• Fisher & Paykel Healthcare collaborated with hospitals in China to develop humidification systems that improve patient comfort during non-invasive ventilation.

• Medtronic plc partnered with healthcare authorities in China to strengthen local manufacturing and distribution of respiratory care devices to improve access and affordability.

This Market Report Will Answer the Following Questions

1. What is the projected size and CAGR of the China Respiratory Care Devices Market by 2031?

2. What technological advancements are transforming the respiratory care landscape in China?

3. How are home-based therapies and tele-respiratory solutions shaping future treatment models?

4. What are the major challenges related to cost, workforce training, and regulatory frameworks?

5. Who are the leading manufacturers, and what strategies are they implementing to expand their presence in China?